Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ2 | O43526 | 7/20 | 0.69 |
| ▸ | KCNQ3 | O43525 | 6/20 | 0.69 |
| ▸ | KCNQ4 | P56696 | 3/20 | 0.69 |
| ▸ | KCNQ5 | Q9NR82 | 3/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3090804 | 1.00 | KCNQ2 (0.69) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL30795095 | 0.91 | KCNQ2 (0.65) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL3095370 | 0.91 | KCNQ2 (0.65) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL3089873 | 0.91 | KCNQ2 (0.71) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL30796024 | 0.91 | KCNQ2 (0.71) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL4972267 | 0.89 | KCNQ2 (0.60) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL3106461 | 0.89 | KCNQ2 (0.69) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL30795670 | 0.89 | KCNQ2 (0.69) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL30794673 | 0.89 | KCNQ2 (0.66) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT | |
| SCHEMBL3106475 | 0.89 | KCNQ2 (0.66) | KCNQ2KCNQ3KCNQ4KCNQ5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| EP-4580679-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | Biohaven Therapeutics Ltd. (VG) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024054807-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND TDP-43 MODULATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024050389-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-07 | — | — | WO | disclosed |